Endothelial function and microcirculation

Endothelial function and microcirculation represent the physiological state and regulatory capacity of the vascular system's inner lining and its smallest vessels. The endothelium acts as a dynamic endocrine organ, secreting factors like nitric oxide (NO) to regulate vascular tone, platelet aggregation, and leukocyte adhesion (Vanhoutte et al., 2017, PubMed). Microcirculation refers to the flow of blood through arterioles, capillaries, and venules, which is essential for tissue oxygenation and nutrient delivery (Guven et al., 2020, PubMed). Dysfunction in these processes is a critical precursor to atherosclerosis, hypertension, and diabetic complications, often characterized by reduced NO bioavailability and increased oxidative stress (Sun et al., 2019, PubMed). While not a single molecular target, pharmacological interventions such as statins, ACE inhibitors, and PDE5 inhibitors are frequently used to restore endothelial health and improve microvascular perfusion (Flammer et al., 2012, PubMed). Monitoring these systems often involves non-invasive techniques like flow-mediated dilation (FMD) or biochemical markers like endothelin-1 and von Willebrand factor (Thijssen et al., 2019, PubMed).

Other names

Endothelial dysfunctionMicrovascular functionVascular homeostasisVasomotor functionMicrovascular reactivity

Pharmacological agents modulate these processes by increasing nitric oxide (NO) bioavailability, reducing reactive oxygen species (ROS), inhibiting the renin-angiotensin-aldosterone system (RAAS), or antagonizing endothelin receptors to restore vascular tone and integrity.